Roche Sues Stanford, Foresight Over Genetic-Sequencing Trade Secrets in Cancer-Detection

Jul 4, 2024, 12:00 AM

Roche has filed a lawsuit against Stanford University and Foresight Diagnostics in California federal court, alleging that Foresight misused its genetic-sequencing trade secrets to develop competing cancer-detection products. Roche is seeking to force Foresight to hand over patent applications related to the disputed technology. This legal action underscores the competitive nature of the cancer-detection market and the importance of genetic-sequencing trade secrets in developing advanced diagnostic tools.